Following the major setback in 2021, Zymeworks has been actively working toward FDA approval for their drug, which they’ve now successfully secured. This approval could signal the continuation of an upward trend. I’m considering a buying opportunity around the $9 range. It’s also worth noting that they were listed on NASDAQ earlier this year. Let me know your thoughts!
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.